Disgraced Clone Expert Barred from Work
By The West Australian,
The West Australian
| 07. 31. 2008
South Korea will not allow disgraced cloning expert Hang Woo-suk to resume human stem cell research, it has been reported.
Hwang's request was turned down by the country's national committee on bioethics, Yonhap news agency reported on Thursday.
The health ministry declined to comment on the report but said it would brief the media on Friday.
"He engaged in unethical and wrongful acts in the past and the committee decided to reject it," a source who took part in the committee meeting was quoted by Yonhap as saying.
"One committee member strongly argued that it would bring shame on the whole country," the source said.
Hwang's claims that he created the first human stem cells through cloning were ruled to be bogus, and he is banned from research using human eggs.
But the scientist is now engaged in animal cloning at the Sooam Biotech Research Foundation, which in December asked for the green light to begin a new embryonic stem cell research project using aborted human eggs.
Still on trial for fraud, embezzlement, ethical breaches and other charges, Hwang has...
Related Articles
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...